U.S. Stock News

NYSE:CRGY
NYSE:CRGYOil and Gas

Did Disciplined Capital Spending and Payouts Just Shift Crescent Energy's (CRGY) Investment Narrative?

Crescent Energy recently reported quarterly results that met or slightly topped expectations, highlighting disciplined capital spending, stable-to-modestly growing production, and an ongoing focus on returning free cash flow to shareholders via dividends and opportunistic buybacks. This approach, combined with analysts’ cautiously positive stance ahead of the February 25, 2026 earnings release, is shaping Crescent’s profile as a U.S. shale operator emphasizing both income and measured...
NasdaqGS:NXPI
NasdaqGS:NXPISemiconductor

NXP Semiconductors (NXPI) Is Up 9.0% After Mixed 2025 Results And 2026 Outlook Shift - Has The Bull Case Changed?

NXP Semiconductors recently reported its fourth quarter and full-year 2025 results, showing quarterly sales rising to US$3,335 million while full-year sales edged down to US$12.27 billion and net income declined to US$2.02 billion, and also issued first quarter 2026 guidance calling for revenue between US$3,050 million and US$3,250 million with diluted EPS of US$4.01 to US$4.41. Alongside the guidance and earnings release, the company announced that long-serving Executive Vice President and...
NYSE:AIT
NYSE:AITTrade Distributors

How Insider Selling and Dividend Hike Will Impact Applied Industrial Technologies (AIT) Investors

In recent weeks, Warren E III Hoffner, Applied Industrial Technologies’ VP and General Manager of Fluid Power, sold 4,000 company shares, while management reiterated confidence in order momentum, engineered solutions, and cash generation despite accounting-driven margin pressures. Alongside this insider sale, Applied emphasized support for its long-term business direction through ongoing bolt-on acquisitions like Thompson Industrial Supply and an 11% dividend increase. With management’s...
NYSE:CNA
NYSE:CNAInsurance

CNA Financial (CNA) Valuation Check After Robust Earnings And Special Dividend Announcement

Earnings, special dividend and higher regular payout put CNA Financial in focus CNA Financial (CNA) is back on investor radar after reporting fourth quarter and full year 2025 earnings, while also announcing a US$2.00 per share special dividend and a higher regular quarterly dividend. See our latest analysis for CNA Financial. At a share price of US$48.69, CNA’s recent 30 day share price return of 4.98% and 90 day share price return of 6.33% sit alongside a 1 year total shareholder return of...
NYSE:BLSH
NYSE:BLSHCapital Markets

ARK Invest Buying And New York BitLicense Shape Bullish Outlook

ARK Invest has purchased NYSE:BLSH shares for ten consecutive trading days, signaling ongoing institutional interest. Bullish recently secured approval for a New York BitLicense, expanding its regulatory footprint in a key U.S. market. The BitLicense allows Bullish to broaden custody services and access a wider pool of professional clients in New York. For Bullish, ticker NYSE:BLSH, the combination of steady ARK Invest buying and a New York BitLicense arrives at a time when the broader...
NYSE:SNA
NYSE:SNAMachinery

How Investors Are Reacting To Snap-on (SNA) Solid Q4 Results And Steady Dividend Amid Softer Sales

Snap-on reported fourth-quarter 2025 results with sales of US$1,231.9 million and diluted EPS of US$4.94, alongside a US$2.44 quarterly dividend declared for payment on March 10, 2026 to shareholders of record on February 24, 2026. While revenue growth was modest and earnings eased slightly for the full year, Snap-on’s uninterrupted quarterly dividend record since 1939 underscores how management is prioritizing consistent shareholder returns amid a turbulent demand backdrop. Now we’ll assess...
NYSE:PHIN
NYSE:PHINAuto Components

PHINIA Growth Story Links 2025 Execution With 2026 Transition Goals

PHINIA Inc. (NYSE:PHIN) reported year over year growth across key business segments in 2025. The company recorded three consecutive quarters of growth in both Fuel Systems and Aftermarket segments. Management reduced debt, improved leverage, and expressed optimism for 2026. Leadership is targeting further market share gains in areas such as Gasoline Direct Injection and alternative fuels. PHINIA, trading as NYSE:PHIN, focuses on Fuel Systems and Aftermarket products that support internal...
NYSE:ABM
NYSE:ABMCommercial Services

Assessing ABM Industries (ABM) Valuation After Recent Share Price Volatility

What ABM Industries (ABM) investors may be watching now ABM Industries (ABM) recently closed at $44.51, with shares showing a 2.46% move over the past day, a small decline over the past month, and a gain across the past 3 months. See our latest analysis for ABM Industries. That 2.46% 1 day share price gain comes after a 6.41% 7 day share price pullback. The 90 day share price return of 10.42% suggests momentum has been rebuilding even as the 1 year total shareholder return of 13.92% remains...
NasdaqCM:FONR
NasdaqCM:FONRMedical Equipment

Fonar (FONR) Margin Compression To 6.7% Reinforces Profitability Concerns After Q2 2026 Results

FONAR (FONR) has just posted its Q2 2026 numbers, with quarterly revenue of about US$26 million and basic EPS of US$0.33, setting the stage against a year of trailing EPS of roughly US$1.08 on revenue of about US$105 million. Over recent quarters, the company has seen revenue move between roughly US$24.9 million and US$27.3 million, while quarterly EPS has ranged from about US$0.11 to US$0.46. This has left investors focused on how these latest figures feed into a story of compressing margins...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

Exelon (EXC) Is Up 9.4% After Dividend Hike And $41.3B Grid Plan Announcement - Has The Bull Case Changed?

Exelon Corporation recently reported fourth-quarter 2025 results showing sales of US$5,412 million and net income of US$593 million, alongside full-year 2025 sales of US$24.26 billion and net income of US$2.77 billion, and its Board declared a regular quarterly dividend of US$0.42 per share payable in March 2026. These earnings beats, paired with an increased dividend and a US$41.30 billion long-term grid and transmission investment plan, highlight Exelon’s focus on regulated infrastructure...
NasdaqGS:SAIA
NasdaqGS:SAIATransportation

Why Saia (SAIA) Is Down 7.4% After Record Q4 Revenue But Weaker Profitability And EPS

In February 2026, Saia, Inc. reported fourth-quarter 2025 revenue of US$789.95 million, roughly flat year on year, while net income fell to US$47.52 million and diluted earnings per share from continuing operations declined to US$1.77. Despite recording record quarterly revenue and completing its first full year as a national network, Saia’s profitability weakened as higher self-insurance costs and a softer freight backdrop pushed its operating ratio to 91.9%. Now we’ll explore how Saia’s...
NYSE:NABL
NYSE:NABLSoftware

Assessing N-able (NABL) Valuation After Recent Share Price Weakness And Fair Value Gap

Why N-able (NABL) is on investors’ radar N-able (NABL) has drawn investor attention after recent trading left the stock at US$5.35, with returns over the past month and past 3 months under pressure and the 1 year total return also negative. With annual revenue of US$497.665 million and net income reported as a US$6.511 million loss, the company’s value score of 6 and an indicated intrinsic discount provide a starting point for investors assessing risk and potential reward. See our latest...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Madrigal Pharmaceuticals (MDGL) Pricing Look Attractive After Recent Share Price Pullback

If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, you will want to look beyond the share price and consider what different valuation methods are signaling. The stock closed at US$464.71, with a 2.7% decline over 7 days, a 7.4% decline over 30 days, a 21.7% decline year to date, a 37.8% gain over 1 year, a 53.2% gain over 3 years, and a 281.3% gain over 5 years. These figures can influence how investors think about both upside potential and...
NYSE:KLAR
NYSE:KLARDiversified Financial

Is Klarna Group (KLAR) Price Slide Creating An Opportunity For Investors?

Wondering if Klarna Group at US$18.11 is a bargain or a value trap? This article walks you through what the current price might really be telling you. The stock has recently seen sharp moves, with a 7 day return of an 11.7% decline and a 30 day return of a 37.6% decline, and it sits 36.6% below its year to date level. Recent headlines around Klarna Group have kept investor attention on the business model and competitive position, which helps frame these price swings. This article uses that...
NYSE:CR
NYSE:CRMachinery

The Bull Case For Crane (CR) Could Change Following Strong Q4 Currency Wins And Antares Vision Deal Plans

Crane NXT recently reported past quarterly results showing around 20% year-on-year sales growth in Q4 2025 and 11% for 2025 overall, driven by strong demand in its currency and authentication technology businesses, new wins across 20 currency denominations, and renewed multiyear contracts with major sports leagues. The company is also expanding capacity in its international currency operations and moving to acquire Antares Vision by mid-2026, highlighting how its micro-optics and...
NasdaqCM:BLFS
NasdaqCM:BLFSLife Sciences

How BioLife’s Exclusive Qkine Cytokine Deal Could Rewire the BLFS Cell and Gene Therapy Story

On 12 February 2026, BioLife Solutions, Inc. announced a multi-year agreement to distribute Qkine Limited’s cytokine and growth factor products globally for cell and gene therapy manufacturing, with plans to integrate select products into BioLife’s CellSeal® Connect vial system. This deal broadens BioLife’s reach into the US$500 million cytokines market, which third-party research suggests could reach about US$1.00 billion by 2030, directly linking its biopreservation tools with critical CGT...
NasdaqCM:NEOV
NasdaqCM:NEOVElectrical

NeoVolta (NEOV) Revenue Surge To US$6.7 Million Tests High P/S Market Narrative

NeoVolta (NEOV) has just posted its Q2 2026 numbers, with Q1 2026 revenue at US$6.7 million and a net loss of US$1.2 million, translating into basic EPS of a US$0.04 loss. The company has seen quarterly revenue move from US$0.6 million in Q1 2025 through US$1.1 million in Q2 2025, US$2.0 million in Q3 2025 and US$4.8 million in Q4 2025 to US$6.7 million in Q1 2026, while EPS over the same stretch ranged from a loss of US$0.03 to a loss of US$0.05 per share. For investors, the latest set of...
NYSE:TPR
NYSE:TPRLuxury

Tapestry’s Direct Approach And Gen Z Gains Support Upgraded Growth Outlook

Tapestry (NYSE:TPR) reported strong quarterly results, highlighting global customer acquisition and growing Gen Z engagement. Management pointed to increased effectiveness of its direct to consumer approach, marketing efforts, and product development. The company raised its full year revenue outlook, citing higher operating margins and improved profitability. Tapestry, the owner of several luxury and premium brands, is drawing attention after this update, especially given its recent share...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

Is It Time To Reassess TPG (TPG) After A 26% One Month Share Price Slide

If you are wondering whether TPG’s share price reflects its underlying worth right now, you are not alone. This article is here to frame the key valuation questions you might be asking. After reaching a recent close of US$49.53, the stock has seen a 10% decline over the last 7 days and a 26.2% decline over the last 30 days, while still showing a 64.5% return over 3 years and mixed results over shorter periods including year to date and the last 12 months. Recent news coverage around TPG has...
NYSE:CSW
NYSE:CSWBuilding

Assessing CSW Industrials (CSWI) Valuation As Investor Sentiment Improves After Earlier Earnings Misses

Why CSW Industrials Is Back On Investors’ Radar Investor sentiment toward CSW Industrials (CSW) has shifted, with buyers returning after a stretch of earnings misses, as attention turns to the company’s multi-year revenue and net income growth and longer term outlook. See our latest analysis for CSW Industrials. At a share price of US$309.48, CSW Industrials has recently seen a 6.63% 7 day share price return but a 6.53% 30 day share price decline, while its 90 day share price return of 28.25%...
NasdaqGS:KC
NasdaqGS:KCIT

Assessing Kingsoft Cloud Holdings (NasdaqGS:KC) Valuation After 31.40% Revenue Growth And Ongoing Buy Ratings

Why Kingsoft Cloud Holdings (KC) Is Back on Investor Radars Kingsoft Cloud Holdings (NasdaqGS:KC) is drawing fresh interest after reporting revenue growth of 31.40% and attracting consistent buy ratings from analysts, even as profitability and cash flow remain key watchpoints for investors. See our latest analysis for Kingsoft Cloud Holdings. Recent trading has been volatile, with a 7 day share price return of 11.99% and a 30 day gain of 21.68%. However, the 1 year total shareholder return...
NYSE:CW
NYSE:CWAerospace & Defense

Curtiss Wright C 17 Win Tests Valuation After Strong Share Run

Curtiss-Wright (NYSE:CW) has been selected by Boeing to supply mission computer technology for the U.S. Air Force C-17 Globemaster III upgrade program. The contract, valued at over $400 million, supports modernization of a key airlift platform used by the U.S. and allied forces. This award expands Curtiss-Wright's role in military aerospace technology and deepens its relationship with Boeing. Curtiss-Wright comes into this contract win with shares at $684.22, after a 1-year return of 112.1%...
NasdaqCM:ONCY
NasdaqCM:ONCYBiotechs

Oncolytics Biotech (ONCY) Is Up 19.7% After FDA Fast Track For KRAS-Mutant mCRC Regimen

On February 4, 2026, Oncolytics Biotech announced that the FDA granted Fast Track Designation to pelareorep combined with bevacizumab and FOLFIRI for second-line treatment of KRAS-mutant, microsatellite-stable metastatic colorectal cancer. The designation is backed by clinical data showing pelareorep-based therapy delivered higher response rates and longer survival measures than existing standard-of-care options in this hard-to-treat subgroup. With the FDA’s Fast Track Designation in place,...
NYSE:FIS
NYSE:FISDiversified Financial

Do FIS’s New Treasury Tech Accolades (FIS) Reveal a Durable Edge in Financial Infrastructure Software?

In recent weeks, Fidelity National Information Services has been recognized with multiple industry honors, including TMI Awards for Best Risk Management Solution and Best Cash & Treasury Management Solution, and leadership positions in IDC and Chartis assessments of treasury, risk and asset-liability management technology. These accolades, alongside renewed analyst coverage, underscore how FIS’s capabilities in AI-enabled treasury and risk tools are shaping perceptions of its role in...